NorthCoast Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

NorthCoast Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$701K	Sell	5,381 -221	-4%	-$33.4K	0.03%	311
2021 Q2	$995K	Sell	5,602 -6,145	-52%	-$1.06M	0.04%	264
2021 Q1	$1.93M	Sell	11,747 -7,596	-39%	-$1.25M	0.08%	166
2020 Q4	$3.19M	Sell	19,343 -3,307	-15%	-$493K	0.14%	110
2020 Q3	$3.23M	Sell	22,650 -2,030	-8%	-$252K	0.16%	102
2020 Q2	$2.72M	Sell	24,680 -14,605	-37%	-$1.62M	0.16%	97
2020 Q1	$3.92M	Sell	39,285 -136	-0.3%	-$17.6K	0.25%	73
2019 Q4	$5.88M	Sell	39,421 -645	-2%	-$87.8K	0.37%	55
2019 Q3	$5.13M	Sell	40,066 -2,083	-5%	-$279K	0.34%	59
2019 Q2	$6.01M	Buy	42,149 +6,668	+19%	+$896K	0.39%	59
2019 Q1	$5.07M	Buy	35,481 +25,396	+252%	+$3.31M	0.33%	62
2018 Q4	$1.25M	Buy	+10,085	New	+$1.5M	0.1%	125
2016 Q4	–	Sell	-9,649	Closed	-$1.17M	–	171
2016 Q3	$1.17M	Buy	+9,649	New	+$1.3M	0.1%	120
2015 Q4	–	Sell	-23,923	Closed	-$3.18M	–	168
2015 Q3	$3.18M	Buy	+23,923	New	+$4.12M	0.17%	70
2014 Q2	–	Sell	-23,313	Closed	-$3.23M	–	179
2014 Q1	$3.23M	Buy	+23,313	New	+$3.51M	0.21%	57

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

NorthCoast Asset Management's JAZZ Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.9% in Q3 2021, selling an estimated $33.4K and leaving 5,381 shares worth $701K. The position accounts for 0.03% of the portfolio, ranked #311.

NorthCoast Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 15 quarters since. The position peaked at $6.01M in Q2 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

NorthCoast Asset Management held 5,381 shares of Jazz Pharmaceuticals worth $701K as of Q3 2021.
NorthCoast Asset Management sold 221 Jazz Pharmaceuticals shares in Q3 2021, an estimated $33.4K.
Jazz Pharmaceuticals made up 0.03% of NorthCoast Asset Management's portfolio in Q3 2021, its #311 holding.
NorthCoast Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 15 quarters since.
NorthCoast Asset Management's Jazz Pharmaceuticals position peaked at $6.01M in Q2 2019.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.